Evaluation of FOXC1 as a therapeutic target for basal-like breast cancer
Crossref DOI link: https://doi.org/10.1038/s41417-018-0010-9
Published Online: 2018-03-06
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mott, Landon
Su, Kai
Pack, Daniel W. http://orcid.org/0000-0003-0410-0423
Text and Data Mining valid from 2018-03-06
Article History
Received: 19 June 2017
Revised: 5 December 2017
Accepted: 15 December 2017
First Online: 6 March 2018
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.